Beneficial effects of simultaneous treatment with 15-deoxyspergualin and monoclonal antibodies to CD45RB and CD 154 on murine islet transplantation recipients

  • Jung, Da-Yeon; 
  • Lee, Hae-Jung; 
  • Lee, Eun-Na; 
  • Lee, Jienny; 
  • Kim, Eun-Young; 
  • ... Kwon, Ghee-Young; 
  • 외 5명
Citations

WEB OF SCIENCE

8
Citations

SCOPUS

8

초록

Background. Treatment of transplant recipients with either 15-deoxyspergualin (DSG) or monoclonal antibodies (mAbs) to T-cell proteins CD45RB and CD 154 (a two-signal blockade) has been shown to prolong islet graft survival. Therefore, we investigated the combined effect of DSG, anti-CD45RB, and anti-CD154 in murine islet model. Methods. Chemically induced diabetic C57BL/6 mice underwent allografting with islets from BALB/c mice or xenografting with rat islets. After transplantation, they were treated with either DSG, the two-signal blockade, or both (the triple treatment). The tolerogenic effects of the posttransplant treatments were measured with an intraperitoneal glucose tolerance test (IPGTT), immunohistology, enzyme-linked immunosorbent assays, and flow cytometry. Results. Blood glucose profiles measured after glucose challenges were improved in all islet recipients. Enhancement of xenograft survival in triple-treated groups was not statistically significant (P = 0.08), compared to graft survival in group received only the two-signal blockade. However, 15 days aft er transplantation, xenografts in the triple-treated group showed a significant decrease in the proportion of CD4(+), CD8(+), and CD4(+) CD45RB(high) T-cells, and in the expression of interleukin-10 and interferon-gamma, relative to grafts in the other treatment groups. In addition, reduced infiltration of the xenografts by CD3(+) T-cells was observed in groups that had received either the two-signal blockade or the triple treatment. With long-term (> 248 days) xenografts, only those in the triple-treated group were free of inflammatory infiltrates. These grafts also exhibited larger islet clusters and contained more insulin- and glucagon-positive cells, relative to grafts in the other treatment groups. Conclusion. Triple treatment has a beneficial effect in murine islet xenotransplantation.

키워드

DSG (15-deoxyspergualin); CD45RB; CD154; islet xenotransplantation; LONG-TERM SURVIVAL; DONOR-SPECIFIC TRANSFUSION; PROLONGED SURVIVAL; ALLOGRAFT SURVIVAL; RAT ISLET; NOD MICE; DIABETES-MELLITUS; PANCREATIC-ISLETS; GRAFT-SURVIVAL; ANTI-CD154
제목
Beneficial effects of simultaneous treatment with 15-deoxyspergualin and monoclonal antibodies to CD45RB and CD 154 on murine islet transplantation recipients
저자
Jung, Da-Yeon; Lee, Hae-Jung; Lee, Eun-Na; Lee, Jienny; Kim, Eun-Young; Park, Hea-Jung; Chang, Chi-Young; Lee, Suk-Koo; Joh, Jae-Won; Kwon, Ghee-Young; Kim, Sung-Joo
DOI
10.1097/01.tp.0000226175.94546.18
발행일
2006-07-27
유형
Article
저널명
Transplantation
권
82
호
2
페이지
188 ~ 195